Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

Fluorescence imaging is the visualization of fluorescent dyes or proteins as labels for molecular processes or structures. It enables a wide range of experimental observations including the ...

Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, and SOFIE Biosciences (SOFIE), a ...

Lantheus (LNTH) is a strong buy with a dominant market position in radiopharmaceuticals and promising growth in Alzheimer's ...

Medical imaging comprises different imaging modalities and processes to image human body for diagnostic and treatment purposes. It is also used to follow the course of a disease already diagnosed ...

A PET scan is often used to help determine a cancer diagnosis. A positron emission tomography (PET) scan uses a tracer with low levels of radiation to find places in your body where cells are ...

based on amyloid-PET, CSF pTau181, and MRI/CT imaging, respectively. 1 Our approach to classifying N through MRI/CT imaging deviates from the standard application of the NIA-AA research criteria and ...

A PET scan can help doctors spot cancer that has spread through the body. A doctor may request one during the melanoma diagnostic process if they suspect advanced melanoma cancer. A PET scan is an ...

In patients with transthyretin amyloid cardiomyopathy, the high-affinity TTR stabilizer, acoramidis, is associated with better clinical outcomes compared with placebo. Acoramidis is associated with ...